相关实验视频

Updated: Jul 18, 2025

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.3K

在高风险的HER2-阴性早期乳腺癌中进行BRCA检测的障碍

Olivia Foroughi1, Shaheen Madraswala1, Jennifer Hayes2

  • 1Health Advances LLC, Newton, MA 02466, USA.

Journal of personalized medicine
|August 25, 2023
PubMed
概括

在HR+/HER2-乳腺癌患者中,由于不清楚的风险标准和付款人限制,生殖线BRCA检测率较低. 协调风险定义至关重要,以改善符合条件的患者获得PARPi治疗的机会.

关键词:
在HR+/HER2−中.乳腺癌 乳腺癌 乳腺癌在早期的早期阶段.gBRCACA 的意思是基因组风险评分 基因组风险评分高风险的高风险的风险.这就是Olaparib.

更多相关视频

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

12.7K
Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

9.1K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K